Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Host: Craig M. McDonald, MD
\n\n Guest: Crystal Proud, MD
\n\n Guest: Aravindhan Veerapandiyan, MD
\n\n\n \n
There are ongoing clinical trials and approvals for new genetic and non-genetic therapies for Duchenne muscular dystrophy. Determining the most suitable therapy for each patient is a developing process. This education covers dystrophin disruption and restoration, recent clinical trial outcomes from different treatment methods, and a case study exploring novel patient management strategies.